Quick Research
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 27,713 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Discovery of a Potent, Cooperative, and Selective SOS1 PROTAC ZZ151 with In Vivo Antitumor Efficacy in KRAS-Mutant Cancers (2023-03-10)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2023) IF: 7.3Products Cited: Calu-1 Cells Line, SW480 [SW-480] Cells Line, CAL-62 Cells Line, LoVo Cells Line, HCT 116 Cells Line, NCI-H460 [H460] Cells Line -
Discovery of BWA-522, a First-in-Class and Orally Bioavailable PROTAC Degrader of the Androgen Receptor Targeting N-Terminal Domain for the Treatment of Prostate Cancer (2023-08-09)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2023) IF: 7.3 -
Discovery and Design of Novel Cyclic Peptides as Specific Inhibitors Targeting CCN2 and Disrupting CCN2/EGFR Interaction for Kidney Fibrosis Treatment (2023-06-06)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2023) IF: 7.3Products Cited: HK-2 Cells Line -
Design, Synthesis, and Biological Evaluation of Novel P2X7 Receptor Antagonists for the Treatment of Septic Acute Kidney Injury (2023-08-15)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2023) IF: 7.3Products Cited: THP-1 Cells Line -
Design, Synthesis, and Biological Evaluation of Proteolysis-Targeting Chimeras as Highly Selective and Efficient Degraders of Extracellular Signal-Regulated Kinase 5 (2023-09-26)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2023) IF: 7.3Products Cited: A-375 Cells Line, HCT 116 Cells Line, Hep G2 Cells Line, MDA-MB-231 Cells Line, NCI-H1975 Cells Line, PC-3 Cells Line, THP-1 Cells Line -
Discovery of Triazolyl Derivatives of Cucurbitacin B Targeting IGF2BP1 against Non-Small Cell Lung Cancer (2023-09-08)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2023) IF: 7.3Products Cited: Hep G2 Cells Line, A549 [A-549] Cells Line, HCT 116 Cells Line, Hela Cells Line -
Discovery of Novel 1,2,3,4-Tetrahydrobenzofuro[2,3-c]pyridine Histone Deacetylase Inhibitors for Efficient Treatment of Hepatocellular Carcinoma (2023-07-27)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2023) IF: 7.3Products Cited: Hep G2 Cells Line, MEM -
SARM suppresses TRIF, TRAF3, and IRF3/7 mediated antiviral signaling in large yellow croaker Larimichthys crocea (2023-01-13)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: M199 -
NK cell-derived exosomes enhance the anti-tumor effects against ovarian cancer by delivering cisplatin and reactivating NK cell functions (2023-01-19)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: IOSE80 Cells Line, NK-92MI Cells Line -
The genetic and epigenetic regulation of CD55 and its pathway analysis in colon cancer (2023-01-18)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: HCT 116 Cells Line, LoVo Cells Line
